Pure BiologicsS.A.Active
Research and experimental development on biotechnology
KRS: 0000712811 NIP: 8943003192 REGON: 02130577200000
Overview
Registry date
2018-01-10
Share capital
$330,759.48
Activity description
PURE Biologics develops new immuno-oncology therapies based on antibody technologies. Its portfolio includes PB004, PB003G and PBA-0405, with updates on Phase 0 studies and FDA clearance to advance these projects. PURE Biologics says it is the first company in Poland focused on developing entirely new biological drugs, not generic or biosimilar medicines.
Registered address
Ul. Szczytnicka 11, 50-382 Wrocław, Poland
Website
purebiologics.comWebsite active
Email
Email address current
Electronic delivery address
AE:PL-43264-33950-CUGUE-31
Industry
Bank accounts
Registered as a VAT taxpayer on 2010-08-01.Active
Authorized Representatives
Ownership
Subsidiaries
| Name | Shares | Share value | % in company | |
|---|---|---|---|---|
| BIO Animalisp. z o.o. | 30 | 4,051.86 USD | 15% |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Medicofarma BiotechS.A. | $330,956.61 | medicofarmabiotech.pl | |
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | |
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | |
| UveraS.A. | $155,384.29 | uvera.eu | |
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | |
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl/contact/wpdsa/ | |
| GenomtecS.A. | $73,665.75 | genomtec.com | |
| InventroS.A. | $12,176.61 | inventro.co | |
| ArthecS.A. | $10,911.16 | arthec.eu | |
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com |
FAQ
Last updated: 2026-07-15